Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.

Recent events indicate an urgent need for researchers and policymakers to relearn the basics.

FDA launches anti-vaping campaign.

An example of sweet intentions bearing stale outcomes.

The only reliable remedy to mitigate shortages of any product is to allow competition in the market.

Private efforts to promote childhood nutrition (specifically breastfeeding) are superior to government “solutions.”

Despite the best of intentions, efforts to regulate vice frequently fail and can lead to harmful secondary effects for those they intend to help.

FDA behind the market in delivering contraceptive apps.

Off-label information policy reform works to broaden what information drug providers can share.

Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.

Telemedicine providers have faced burdensome and complex regulatory structures at the state and federal level.